Rochester, NY (PRWEB) July 19, 2014
High-Risk HPV (HR-HPV) impacts African American women more than their European American peers. According to Dr. Bannister and colleagues, “Cervical cancer incidence and mortality rates are higher in African Americans (AA) than in European Americans (EA).” (1) During the study, African American women were found to take more than twice as long as European American women to clear the HPV infection. Researchers wrote that “the time required for 50% of participants to clear a HR-HPV infection was 601 days for AA and 316 days for EA women.” (1) This means that the HPV stays longer in the AA bodies, and as a result, has a higher chance of transforming into warts or cancer. The reason for this disparity is currently unknown. Dr. Bannister is from the Department of Drug Discovery and Biomedical Sciences at the South Carolina College of Pharmacy in the University of South Carolina.
Learn more about HPV symptoms.
polyDNA therefore recommends that African American women infected with the human papillomavirus (HPV) take Novirin or Gene-Eden-VIR. The formula of these natural antiviral products was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Novirin and Gene-Eden-VIR formula is effective against the HPV, and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the HPV reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (2) The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (2)
Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.
Many doctors recommend that women of every ethnicity get vaccinated with one of the two HPV vaccines that are currently on the market. However, many African American women have a negative attitude toward Gardasil and Cervarix, the two available HPV vaccines. (See the Journal of Adolescent Health, from December 2013) (3)
There may be many reasons African American women hesitate to become vaccinated. For instance, it is possible that these women realize that these vaccines are designed to protect non-infected women. In contrast, they are ineffective in women who are already infected. As Cancer.gov says on its website concerning the two available HPV vaccines, they do not treat HPV in individuals already infected with the virus (4). In addition, WebMD said that “These HPV vaccines are not foolproof. They do not protect against all of the 100-plus types of HPV (5).” This quote was found on a page last reviewed by Dr. Kimball Johnson, MD on August 13, 2012.
It is also possible that these women are familiar with the disclaimers on the Gardasil website, which notes that “GARDASIL may not fully protect everyone, nor will it protect against diseases caused by other HPV types… GARDASIL does not prevent all types of cervical cancer… GARDASIL does not treat cervical cancer or genital warts (6).”
Based on the evidence presented above, polyDNA recommends that African American women infected with HPV take Novirin or Gene-Eden-VIR.
All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured. To contact a polyDNA representative, please call 585-250-9999 or E-mail info (at) gene-eden-vir.com.
(1) Banister CE1, Messersmith AR1, Cai B2, Spiryda LB3, Glover SH4, Pirisi L5, Creek KE1. Disparity in High Risk HPV Persistence between African American and European American Women of College Age. J Infect Dis. 2014 Jul 15. pii: jiu394.
(2) Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8
(3) Amanda Gelman, Elizabeth Miller, M.D., Ph.D., Eleanor Bimla Schwarz, M.D., M.S., Aletha Y. Akers, M.D., M.P.H., Kwonho Jeong, Sonya Borrero, M.D. Racial Disparities in Human Papillomavirus Vaccination: Does Access Matter? Journal of Adolescent Health Volume 53, Issue 6 , Pages 756-762, December 2013
(4) Cancer.gov - National Cancer Institute - Human Papillomavirus (HPV) Vaccines
(5) WebMD - HPV/Genital Warts Health Center - HPV Vaccines - Reviewed by Kimball Johnson, MD on August 13, 2012